{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:43:44Z","timestamp":1777293824924,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,1,29]],"date-time":"2011-01-29T00:00:00Z","timestamp":1296259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10096-011-1165-6","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T12:14:37Z","timestamp":1296216877000},"page":"853-855","source":"Crossref","is-referenced-by-count":31,"title":["Use of procalcitonin (PCT) to guide discontinuation of antibiotic use in an unspecified sepsis is an antimicrobial stewardship program (ASP)"],"prefix":"10.1007","volume":"30","author":[{"given":"Y. X.","family":"Liew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Chlebicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Y.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,29]]},"reference":[{"key":"1165_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs need drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1\u201312","journal-title":"Clin Infect Dis"},{"key":"1165_CR2","doi-asserted-by":"crossref","unstructured":"Slama TG, Amin A, Brunton SA et al. (2005) A clinician's guide to the appropriate and accurate use of antibiotics: the Council for Appropriate and Rational Antibiotic Therapy (CARAT) criteria. Am J Med 118(Suppl 7A):1\u20136","DOI":"10.1016\/j.amjmed.2005.05.007"},{"key":"1165_CR3","doi-asserted-by":"crossref","unstructured":"Larson E (2007) Community factors in the development of antibiotic resistance. Annu Rev Public Health 28:435\u2013447","DOI":"10.1146\/annurev.publhealth.28.021406.144020"},{"key":"1165_CR4","unstructured":"Sehulster L, Chinn RY, CDC, HICPAC (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 52(rr10):1\u201342"},{"key":"1165_CR5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1001\/archinte.157.15.1689","volume":"157","author":"GL Fraser","year":"1997","unstructured":"Fraser GL, Stogsdill P, Dickens JD, Wennberg DE, Smith RP, Prato BS (1997) Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch Intern Med 157:1689\u20131694","journal-title":"Arch Intern Med"},{"issue":"3","key":"1165_CR6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1164\/ajrccm.164.3.2009052","volume":"164","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Holeckova K, Froidevaux C et al (2001) Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164(3):396\u2013402","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1165_CR7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1164\/rccm.200708-1238OC","volume":"177","author":"V Nobre","year":"2008","unstructured":"Nobre V, Harbarth S, Graf JD et al (2008) Use of PCT to shorten antibiotic treatment duration in septic patients. Am J Respir Crit Care Med 177(5):498\u2013505","journal-title":"Am J Respir Crit Care Med"},{"key":"1165_CR8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","volume":"363","author":"M Christ-Crain","year":"2004","unstructured":"Christ-Crain M, Jaccard-Stolz D, Bingisser R et al (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600\u2013607","journal-title":"Lancet"},{"key":"1165_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1164\/rccm.200512-1922OC","volume":"174","author":"M Christ-Crain","year":"2006","unstructured":"Christ-Crain M, Stolz D, Bingisser R et al (2006) Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174:84\u201393","journal-title":"Am J Respir Crit Care Med"},{"key":"1165_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1378\/chest.06-1500","volume":"131","author":"D Stolz","year":"2007","unstructured":"Stolz D, Christ-Crain M, Bingisser R et al (2007) Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131:9\u201319","journal-title":"Chest"},{"key":"1165_CR11","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/archinte.168.18.2000","volume":"168","author":"M Briel","year":"2008","unstructured":"Briel M, Schuetz P, Mueller B et al (2008) Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch Intern Med 168:2000\u20132007","journal-title":"Arch Intern Med"},{"key":"1165_CR12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","volume":"375","author":"L Bouadma","year":"2010","unstructured":"Bouadma L, Luyt CE, Tubach F et al (2010) Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 375:463\u2013474","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1165-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1165-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1165-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T01:52:15Z","timestamp":1559958735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1165-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,29]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1165"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1165-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,29]]}}}